Status check updated to Tesamorelin in 대한민국. US research-market identity with a separate FDA-licensed medicine record.
Direct answer / 대한민국Can you buy Tesamorelin in 대한민국?
US research-market identity with a separate FDA-licensed medicine recordThis record resolves seller-labelled 10 mg tesamorelin research listings. EGRIFTA WR is a separate FDA-licensed prescription product with a specific application, 11.6 mg presentation, indication, label, and regulated supply chain. The research listings do not inherit that approval.
- 01
Resolve the nameResearch price board
- 02
Check 대한민국Research price board
- 03
Verify the exact offerProduct, seller, and supply route must match
Identity recordUS research-market identity with a separate FDA-licensed medicine record
What Tesamorelin resolves to
This record resolves seller-labelled 10 mg tesamorelin research listings. EGRIFTA WR is a separate FDA-licensed prescription product with a specific application, 11.6 mg presentation, indication, label, and regulated supply chain. The research listings do not inherit that approval.
- Evidence lane
- Research price board
- Current record
- 4 of 5 rows in stock
- Checked
- Jul 23, 2026
EgriftaTH9507
Destination record식약처 품목과 심평원 약국 기록 확인 필요
What 대한민국 still has to prove
대한민국에서 펩타이드, 펩타이드 의약품, 체중 관리 약물, 연구용 물질을 검색할 때 식품의약품안전처 의약품 허가 데이터와 건강보험심사평가원 병원·약국 찾기를 이용하는 검증 가이드입니다. 국내 상품, 수입품, 병원 서비스, 연구용 표시를 같은 범주로 합치지 않고 제품과 기관의 공식 기록을 분리해 확인합니다.
- Comparison mode
- 원화 / 식약처 품목 및 심평원 약국 기록
- Price coverage
- 검증 기준을 충족한 국내 판매자 표 없음
- Guide updated
- 2026년 7월 18일
Evidence coverageRouting records only
No compound-specific official record is attached to this exact pairing yet. That is an evidence gap, not proof of approval, prohibition, availability, or absence. Use the country guide and official product and seller routes to verify the exact offer.
Open the full country check →Result boundaryIdentity match ≠ destination approval ≠ verified sellerThis check routes each question to the right record. It is not a medical recommendation, legal opinion, local availability claim, or commercial ranking.